Impel Pharma falls as Q1 results miss estimates

IPI Legacy Liquidation Co

12/05/2023 13:54

** Shares of drugmaker Impel Pharmaceuticals Inc  IMPL.O 
down ~11% at $2.04 premarket
    ** Impel reports Q1 revenue of $4.37 mln, below analysts'
expectation of $5.7 mln, according to Refinitiv data
    ** Quarterly loss at $1.27/share also wider than estimated
loss of 90 cents/share
    ** Impel shares down ~54% this year

 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))